Image 1 of 1
MICC (10mL Vial)
MICC is a compounded lipotropic injection containing a specialized combination of methionine, inositol, choline, and vitamin B12. These nutrients play important roles in the body's natural metabolic processes, including fat metabolism, cellular function, and energy production.
Potential Benefits
Metabolic Support: Provides nutrients involved in the body's natural processing of fats and carbohydrates.
Energy Production: Contains vitamin B12, which is essential for normal cellular energy metabolism.
Fat Metabolism: Choline supports normal liver function and the transportation of fats throughout the body.
Cellular Health: Methionine and inositol participate in important cellular and metabolic processes.
Nutritional Support: May help supplement nutritional intake during a medically supervised weight management program.
Weight Management Support: Can be used alongside an individualized weight loss program, although MICC itself has not been proven to produce significant weight loss.
Active Ingredients
Methionine 25 mg
Supports protein synthesis and metabolic processes
Inositol 50 mg
Supports cellular signaling and metabolic function
Choline 50 mg
Supports liver health and lipid metabolism
Cyanocobalamin (B12) 0.33 mg
Supports red blood cell formation, nerve health, and energy metabolism
Administration and Possible Side Effects
MICC is administered by injection under the supervision of a licensed healthcare provider. Olympia's product page lists intramuscular and subcutaneous administration, although another Olympia educational page specifies intramuscular use only. The dispensed product label and pharmacy instructions should determine the appropriate route.
Possible side effects include injection-site irritation, redness, temporary fatigue, nausea, and rare allergic reactions.
Precautions Avoid if you have schizophrenia, acidosis, liver disease, hereditary optic nerve atrophy (Leber’s disease), or a sulfa allergy.
Important: MICC is a compounded preparation and is not FDA-approved for weight loss. Although its ingredients have established nutritional functions, clinical evidence that MICC injections independently accelerate fat loss or increase energy in patients without nutrient deficiencies is limited.
MICC is a compounded lipotropic injection containing a specialized combination of methionine, inositol, choline, and vitamin B12. These nutrients play important roles in the body's natural metabolic processes, including fat metabolism, cellular function, and energy production.
Potential Benefits
Metabolic Support: Provides nutrients involved in the body's natural processing of fats and carbohydrates.
Energy Production: Contains vitamin B12, which is essential for normal cellular energy metabolism.
Fat Metabolism: Choline supports normal liver function and the transportation of fats throughout the body.
Cellular Health: Methionine and inositol participate in important cellular and metabolic processes.
Nutritional Support: May help supplement nutritional intake during a medically supervised weight management program.
Weight Management Support: Can be used alongside an individualized weight loss program, although MICC itself has not been proven to produce significant weight loss.
Active Ingredients
Methionine 25 mg
Supports protein synthesis and metabolic processes
Inositol 50 mg
Supports cellular signaling and metabolic function
Choline 50 mg
Supports liver health and lipid metabolism
Cyanocobalamin (B12) 0.33 mg
Supports red blood cell formation, nerve health, and energy metabolism
Administration and Possible Side Effects
MICC is administered by injection under the supervision of a licensed healthcare provider. Olympia's product page lists intramuscular and subcutaneous administration, although another Olympia educational page specifies intramuscular use only. The dispensed product label and pharmacy instructions should determine the appropriate route.
Possible side effects include injection-site irritation, redness, temporary fatigue, nausea, and rare allergic reactions.
Precautions Avoid if you have schizophrenia, acidosis, liver disease, hereditary optic nerve atrophy (Leber’s disease), or a sulfa allergy.
Important: MICC is a compounded preparation and is not FDA-approved for weight loss. Although its ingredients have established nutritional functions, clinical evidence that MICC injections independently accelerate fat loss or increase energy in patients without nutrient deficiencies is limited.
